Participants 78 111 3
advanced nasopharyngeal carcinoma
Participants 368 394 4
patients with advanced NPC
Participants 396 572 7
PATIENTS AND METHODS From December 1993 to April 1999, 284 patients with 1992 American Joint Committee on Cancer stage III to IV (M0) NPC were randomly allocated into two arms.
Participants 931 1001 3
RESULTS Baseline patient characteristics were comparable in both arms.
Participants 1729 1833 3
CONCLUSION We conclude that CCRT is superior to RT alone for patients with advanced NPC in endemic areas
